— Know what they know.
Not Investment Advice

NSRX Earnings

Nasus Pharma Ltd.
1W: +12.6% 1M: +4.0% 3M: +13.9% YTD: -48.1% 1Y: -34.7%
$3.92
+0.10 (+2.75%)
 
Weekly Expected Move ±8.5%
$3 $4 $4 $4 $5
AMEX · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 54 · $33.8M mcap · 3M float · 0.829% daily turnover · Short 23% of daily vol
Last Earnings 2026-08-17
EPS
$-0.54
▼ Miss -100.0%
Revenue
—
Next Earnings Qtr ending 2026-12-30 · date TBD
EPS Estimate
$-0.58
Range: $-0.73 - $-0.31

Estimate vs Actual

Earnings Surprise History

0/1
EPS Beats
0/1
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-08-31 annual 2030-12-31 $— $1.39 ▲ 1.39 $— $49,964,000
2026-08-31 annual 2029-12-31 $— $0.27 ▲ 0.27 $— $24,398,000
2026-08-31 annual 2028-12-31 $— $-0.51 ▼ 0.51 $— $5,275,000
2026-08-31 annual 2027-12-31 $— $-1.13 ▼ 1.13 $— $—
2026-08-31 annual 2026-12-31 $— $-1.13 ▼ 1.13 $— $—
2026-08-31 annual 2025-12-31 $— $-0.69 ▼ 0.68 $— $—
2026-08-31 quarter 2026-12-30 $— $-0.58 ▼ 0.58 $— $—
2026-08-31 quarter 2026-09-30 $— $-0.24 ▼ 0.24 $— $—
2026-08-31 quarter 2026-06-30 $— $-0.18 ▼ 0.18 $— $—
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms